NCT04565769 · ACTIVE NOT RECRUITING
Cognitive Function in Melanoma Patients Treated With Adjuvant Immune Checkpoint Inhibitors
This study follows melanoma patients at Aarhus University Hospital in Denmark who are about to start immune checkpoint inhibitors, a type of immunotherapy. Researchers test thinking and memory before treatment and again nine months later, comparing results with healthy matched volunteers. It is an observational study with no new intervention, and no phase was listed.
You may qualify if
- Confirmed diagnosis of melanoma and scheduled for ICI treatment at Aarhus University Hospital (AUH), Denmark. The healthy control group will consist of an age- and gender- matched sample of participants.
You're excluded if
- Previous treatment with immunotherapy
- Neurodegenerative diseases (dementia etc.)
- Substance abuse
- Known progressive psychiatric diseases (e.g., Schizophrenia)
- Other confirmed diagnoses with underlying cognitive impairment
- Insufficient Danish proficiency
The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.
Eligibility criteria as of 2024-12-06